Study Design
A prospective, comparative, open-label, 2-armed, randomized controlled diagnostic trial was conducted from 7 September 2020 to 20 September 2021 at the outpatient clinics of the medical center Saint Louis of Temnaore and the health facility of Pella in the health district of Nanoro in Burkina Faso. Briefly, any outpatient attending the participating health centers in the health district of Nanoro, fulfilling the inclusion criteria below, was invited to participate in the study by signing the informed consent form [